CUE - Cue Biopharma, Inc.
0.7661
0.047 6.174%
Share volume: 75,774
Last Updated: 04-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.14%
PREVIOUS CLOSE
CHG
CHG%
$0.72
0.05
0.07%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-09-2023 | 08-08-2023 | 11-03-2023 | 03-28-2024 | 05-09-2024 | 05-09-2024 | 08-14-2024 | 11-14-2024 | |
| Total revenue | 187.000 K | 1.382 M | 2.100 M | 1.821 M | 1.717 M | 1.717 M | 2.658 M | 3.336 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 187.000 K | 1.382 M | 2.100 M | 1.821 M | 1.717 M | 1.717 M | 2.658 M | 3.336 M | |
| 639.04% | 51.95% | -13.29% | -5.71% | 0.00% | 54.80% | 25.51% | |||
| Operating expenses | 13.567 M | 14.899 M | 13.519 M | 15.497 M | 14.385 M | 14.385 M | 13.041 M | 12.248 M | |
| Selling general and admin | 4.176 M | 4.249 M | 3.645 M | 4.610 M | 4.186 M | 4.186 M | 3.511 M | 2.867 M | |
| Research and development | 9.391 M | 10.650 M | 9.874 M | 10.887 M | 10.199 M | 10.199 M | 9.530 M | 9.381 M | |
| Total expenses | 13.567 M | 14.899 M | 13.519 M | 15.497 M | 14.385 M | 14.385 M | 13.041 M | 12.151 M | |
| 9.82% | -9.26% | 14.63% | -7.18% | 0.00% | -9.34% | -6.82% | |||
| Operating income | -13.380 M | -13.517 M | -11.419 M | -13.676 M | -12.668 M | -12.668 M | -10.383 M | -8.815 M | |
| Ebit | -13.380 M | -13.517 M | -11.419 M | -13.676 M | -12.668 M | -12.668 M | -10.383 M | -8.815 M | |
| Pretax income | -13.109 M | -13.185 M | -11.005 M | -13.434 M | -12.347 M | -12.347 M | -10.171 M | -8.660 M | |
| 0.58% | -16.53% | 22.07% | -8.09% | 0.00% | -17.62% | -14.86% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -13.109 M | -13.185 M | -11.005 M | -13.434 M | 0.000 | -12.347 M | 0.000 | 0.000 | |
| -0.58% | 16.53% | -22.07% | 100.00% | 100.00% | |||||
| Net income | -13.109 M | -13.185 M | -11.005 M | -13.434 M | -12.347 M | -12.347 M | -10.171 M | -8.660 M | |
| -0.58% | 16.53% | -22.07% | 8.09% | 0.00% | 17.62% | 14.86% |
